In Canada, we market a rapidly growing and diversified portfolio of Health Canada-approved pharmaceuticals, including injectable and ophthalmic prescription medicines.
For 45 years, Hikma Pharmaceuticals has been making high-quality medicines and making them accessible to the people who need them.
We are a leading global pharmaceutical company with a strong presence in the Middle East and North Africa (MENA) region, Europe, Canada, and the United States. We manufacture and market a wide range of generic and branded products, including branded generics, injectables, and specialty pharmaceuticals.
We have 760 products, 32 manufacturing plants, 8 R&D centres and employ c8,800 employees worldwide*.
We have a strong focus on sustainability and focus on four areas where we can make a positive impact: advancing health and wellbeing; empowering our people; protecting the environment; and building trust through quality in everything we do.
*(Feb. 2023)
Canada Products
We have a broad range of quality medicines and a growing pipeline of new, differentiated products.
Canada Medical Information Enquiries, Complaints and Adverse Events Reporting
For further information or to report adverse events in Canada, please contact Canada_DrugSafety@hikma.com